For the year ending 2025-12-31, EXFY had $13,790K increase in cash & cash equivalents over the period. $20,072K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -21,389 |
| Depreciation and amortization | 8,460 |
| Reduction of operating lease right-of-use assets | 575 |
| Loss on impairment, receivables and sale or disposal of equipment | -603 |
| Stock-based compensation | 26,578 |
| Amortization of debt issuance costs | 133 |
| Deferred tax assets | 5 |
| Accounts receivable, net | 355 |
| Settlement assets, net | 2,054 |
| Prepaid expenses | -6,501 |
| Other current assets | 6,852 |
| Other assets | 135 |
| Accounts payable | 91 |
| Accrued expenses and other liabilities | 9,727 |
| Operating lease liabilities | -588 |
| Settlement liabilities | -1,300 |
| Other liabilities | 89 |
| Net cash provided by operating activities | 20,089 |
| Purchase of property and equipment | 17 |
| Software development costs | 3,538 |
| Net cash used in investing activities | -3,555 |
| Principal payments of finance leases | 140 |
| Principal payments of outstanding debt | 0 |
| Payments for debt issuance costs | 153 |
| Repurchases of early exercised stock options | 0 |
| Proceeds from common stock purchased under matching plan | 6,321 |
| Proceeds from issuance of common stock on exercise of stock options | 323 |
| Payments for employee taxes withheld from stock-based awards | 0 |
| Repurchase and retirement of common stock | 9,095 |
| Net cash used in financing activities | -2,744 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 13,790 |
| Cash and cash equivalents and restricted cash, beginning of period | 90,834 |
| Cash and cash equivalents and restricted cash, end of period | 104,624 |
Expensify, Inc. (EXFY)
Expensify, Inc. (EXFY)